SHENGDA BIO-PHARM(603079)
Search documents
圣达生物(603079) - 2018 Q1 - 季度财报
2018-04-23 16:00
Financial Performance - Net profit attributable to shareholders increased by 83.76% to CNY 24,049,962.38 year-on-year[6] - Operating revenue rose by 1.06% to CNY 117,960,077.67 compared to the same period last year[6] - Basic earnings per share increased by 36.36% to CNY 0.30[6] - The net profit after deducting non-recurring gains and losses increased by 76.34% to CNY 22,709,249.44[6] - The operating profit for Q1 2018 reached CNY 36,987,220.35, significantly up from CNY 15,889,604.85 in the same period last year, representing a growth of 132.5%[30] - The net profit for Q1 2018 was CNY 31,446,679.73, compared to CNY 13,614,623.29 in the previous year, marking an increase of 131.5%[30] - The total comprehensive income for Q1 2018 was CNY 31,446,679.73, compared to CNY 13,614,623.29 in the previous year, showing an increase of 131.5%[30] Cash Flow - The net cash flow from operating activities was CNY 1,023,246.79, a significant recovery from a negative cash flow of CNY -3,241,257.25 in the previous year[6] - The cash flow from operating activities increased significantly, indicating improved operational efficiency[13] - The cash flow from operating activities was CNY 129,231,139.37, up from CNY 110,415,806.11 in the previous year, reflecting a growth of 17%[31] - Total cash inflow from operating activities amounted to ¥138,225,701.76, up from ¥113,694,216.11 year-over-year, reflecting a growth of approximately 21.6%[32] - Cash outflow from operating activities was ¥137,202,454.97, compared to ¥116,935,473.36 in the previous year, indicating an increase of about 17.3%[32] - The net cash flow from financing activities was ¥8,493,268.15, down from ¥16,073,915.70 in the previous year, showing a decline of approximately 47.2%[33] Assets and Liabilities - Total assets increased by 2.14% to CNY 1,007,113,756.05 compared to the end of the previous year[6] - Current liabilities decreased to CNY 212,792,452.61 from CNY 215,466,211.23, a reduction of 1.56%[20] - Total liabilities decreased to CNY 214,356,680.79 from CNY 217,272,884.81, a decline of 1.39%[20] - Owner's equity increased to CNY 792,757,075.26 from CNY 768,707,112.88, representing a growth of 3.12%[20] - Cash and cash equivalents decreased to CNY 202,102,648.39 from CNY 211,175,955.00, a decline of 4.99%[22] - Inventory increased to CNY 89,190,151.10 from CNY 66,113,381.99, an increase of 34.83%[23] Shareholder Information - The number of shareholders reached 8,125 at the end of the reporting period[10] - The largest shareholder, Zhejiang Shengda Group Co., Ltd., holds 28.94% of the shares, amounting to 23,150,914 shares[10] Expenses - Financial expenses surged by 466.75% from CNY 1,547,043.50 to CNY 8,767,812.20 mainly due to significant exchange losses from the appreciation of the RMB against the USD[13] - Tax expenses increased by 50.72% from CNY 3,184,675.39 to CNY 4,799,920.71 as a result of higher total profits[13] - The tax expenses for Q1 2018 were CNY 5,505,630.42, compared to CNY 2,409,617.35 in the previous year, which is an increase of 128.5%[30] Investments and Purchases - The company plans to purchase land use rights for approximately CNY 68 million to support its strategic development[15] - The company terminated a major asset restructuring plan after multiple negotiations with transaction parties[15] - Cash paid for purchasing goods and services increased by 33.60% from CNY 67,958,206.84 to CNY 90,793,546.02 due to higher material payments[13] - The company received ¥90,000,000.00 from investment recoveries during the quarter, indicating active management of investment portfolios[32] - The company reported a significant increase in sales revenue from services, reaching ¥99,075,396.43, compared to ¥74,463,274.51 in the previous year, marking an increase of approximately 33.0%[35]
圣达生物(603079) - 2017 Q3 - 季度财报
2017-10-24 16:00
Financial Performance - Net profit attributable to shareholders increased by 6.22% to CNY 57,603,684.16 for the first nine months[6] - Net profit attributable to shareholders after deducting non-recurring gains and losses increased by 8.99% to CNY 49,455,902.67[6] - The net profit for the period showed a significant increase, with retained earnings growing by 43.41% to ¥190,314,880.06 from ¥132,711,195.90, reflecting improved profitability[12] - Net profit for Q3 2017 was ¥15,962,182.14, a significant increase of 157.5% compared to ¥6,206,674.78 in Q3 2016[23] - The net profit for the first nine months of 2017 reached CNY 48,718,946.88, compared to CNY 57,680,154.10 for the same period in 2016, reflecting a decrease of approximately 15.5%[28] Revenue and Sales - Revenue for the first nine months decreased by 3.01% to CNY 369,606,326.00 compared to the same period last year[6] - The company’s total revenue from sales of goods and services for the first nine months was CNY 357,349,764.98, a decrease from CNY 386,195,980.24 year-on-year[29] - Total operating revenue for Q3 2017 reached ¥118,882,493.14, an increase of 15.5% compared to ¥103,180,762.24 in Q3 2016[22] Assets and Liabilities - Total assets increased by 33.49% to CNY 989,694,465.25 compared to the end of the previous year[6] - Total liabilities increased, with long-term borrowings rising by 45.45% to ¥40,000,000.00 from ¥27,500,000.00, driven by funding needs for construction projects[12] - Total liabilities decreased to ¥235,993,870.64 from ¥301,351,813.02, a reduction of about 21.7%[17] - Current assets rose to ¥634,998,763.02, compared to ¥386,386,051.44, indicating a growth of about 64.3%[16] Cash Flow - Operating cash flow increased by 37.72% to CNY 87,153,094.13 for the period from January to September[6] - Cash flow from operating activities for the first nine months was CNY 87,153,094.13, up from CNY 63,281,052.24 year-on-year, indicating a growth of about 37.8%[29] - Cash inflow from financing activities included ¥301,800,000.00 from the initial public offering, indicating strong investor interest[13] - Cash inflow from financing activities increased significantly to RMB 369,800,000.00 from RMB 80,000,000.00, marking a growth of 362.3%[33] Shareholder Information - Total number of shareholders reached 11,255 at the end of the reporting period[10] - The top ten shareholders hold a combined 73.44% of the total shares, with Zhejiang Shengda Group holding 28.94%[10] Expenses - Sales expenses decreased by 46.22% to ¥8,813,116.03 from ¥16,388,377.01, attributed to reduced employee compensation and advertising costs[12] - Management expenses decreased to ¥18,523,018.09 in Q3 2017 from ¥25,389,385.10 in Q3 2016, a decline of 27.1%[22] Future Outlook - The company anticipates continued growth and expansion, with plans for new product development and market strategies in the upcoming quarters[14]